Societal Color Logo and Tagline.png
Societal CDMO Announces Signing of More Than $9 Million Sales and Purchase Agreement With David Weekley Homes for Excess Lakefront Land
August 16, 2022 07:00 ET | Societal CDMO, Inc.
Established Homebuilder to Purchase Approximately 121 Acres in Gainesville, Georgia, for Residential Development Proceeds from Sale to Strengthen Societal CDMO’s Corporate Balance Sheet Through...
Societal Color Logo and Tagline.png
Societal CDMO Reports Second Quarter 2022 Financial Results
August 10, 2022 16:05 ET | Societal CDMO, Inc.
Recorded Q2 Revenue of $23.2 Million, a 29% Increase Compared to Prior Year Period Signed Multiple New Business Agreements Spanning Clinical Trial Support, Commercial Manufacturing and Packaging ...
Societal Color Logo and Tagline.png
Societal CDMO Adds Three New Customers, Signing Agreements to Provide CDMO Services Supporting Clinical Development of Several Novel Therapeutic Candidates
August 04, 2022 07:00 ET | Societal CDMO, Inc.
Contracted Activities Touch Upon Broad Range of Societal’s Offerings from Clinical Trial Services to Formulation Development to cGMP Manufacturing Work to be Conducted Collaboratively at Societal’s...
Societal Color Logo and Tagline.png
Societal CDMO to Report Financial Results for Second Quarter 2022 on August 10, 2022
August 03, 2022 16:05 ET | Societal CDMO, Inc.
SAN DIEGO, Calif. and GAINESVILLE, Ga., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization...
Global Pharmaceutical Isolators Market Report 2022: Increase in Use of High-potency Active Pharmaceutical Ingredients Driving Growth
July 26, 2022 06:58 ET | Research and Markets
Dublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical Isolators Market (High-value & Low-value): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)" report has...
Societal Color Logo and Tagline.png
Societal CDMO Selected To Provide Tech Transfer And Manufacturing Services To Support Clinical Development Of An Oral Solid Dose Product In Europe
July 20, 2022 07:00 ET | Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., July 20, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving...
The Worldwide Formulation Development Outsourcing Industry is Expected to Reach $61.4 Billion by 2030
July 20, 2022 06:48 ET | Research and Markets
Dublin, July 20, 2022 (GLOBE NEWSWIRE) -- The "Global Formulation Development Outsourcing Market Size, Share & Trends Analysis Report by Service (Preformulation, Formulation Development), by...
Outlook on the Oral Solid Dosage Contract Manufacturing Global Market to 2030 - Featuring Jubilant, Patheon and Recipharm Among Others
July 18, 2022 07:43 ET | Research and Markets
Dublin, July 18, 2022 (GLOBE NEWSWIRE) -- The "Global Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report by Product Type (Tablets, Capsules), by Mechanism...
Societal Color Logo and Tagline.png
Societal CDMO Announces Signing of Amendment to License and Supply Agreement With Lannett for Marketing of Verapamil PM and Verelan SR Products
July 12, 2022 07:00 ET | Societal CDMO, Inc.
Societal to Receive Greater Portion of Profit Sharing from Verapamil PM Product Sales Societal Awarded Potential New GMP Manufacturing Agreements for Multiple Additional Lannett Products SAN DIEGO...
Societal Color Logo and Tagline.png
Societal CDMO Reports Inducement Grants for New Staff
July 07, 2022 16:05 ET | Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., July 07, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving...